Arm1: Clinical Trials

6 trials of Arm1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 not yet recruiting, 1 completed. 5 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Not yet recruiting 2, Unknown 2, Completed 1
Not applicable1Unknown 1
Phase 11Unknown 1

Follow Arm1: new trials by email Literature Review of Arm1 trials Research Report on Arm1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer
Arm1, Arm 2, Arm 3 - CRC (Colorectal Cancer), BRAF
Phase 2Not yet recruitingSun Yat-sen University912026-11-302026-07-21
Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Tunlametinib + Cetuximab β, Tunlametinib + Fulzerasib - Lung Cancer (NSCLC)
Phase 2Not yet recruitingSun Yat-sen University552026-03-152026-03-11
A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates
Arm1, Arm 2 - Ulcerative Colitis
Phase 2CompletedZydus Lifesciences Limited242024-04-082024-12-20
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
No stress testing, stress testing - Coronary Artery Disease, Percutaneous Coronary Intervention
Not applicableUnknownAssistance Publique - Hôpitaux de Paris26642021-09-302024-06-03
Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study
Arm1, Arm 2, Arm 3 - Oral Squamous Cell Carcinoma, Carcinoma of Buccal Mucosa
Phase 2UnknownTata Memorial Hospital642015-08-182022-04-28
Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix
Paclitaxel and carboplatin - Metastatic Carcinoma to the Uterine Cervix, Recurrent Carcinoma Cervix
Phase 1 / Phase 2UnknownAll India Institute of Medical Sciences402013-11-012015-07-08

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Colitis, Ulcerative (1)  ·  Colorectal Neoplasms (1)  ·  Coronary Artery Disease (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Myocardial Ischemia (1)  ·  Recurrence (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Tongue Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Sun Yat-sen University (2)  ·  All India Institute of Medical Sciences (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Tata Memorial Hospital (1)  ·  Zydus Lifesciences Limited (1)

Countries

India (3)  ·  China (1)  ·  France (1)

Top investigators

Dr. Deven Parmar, MD,FCP (1)  ·  Nadjib Hammoudi, MD PHD (1)  ·  Sudhir V Nair, MBBS, MS,MCh (1)